Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87.4M
Number of holders
43
Total 13F shares, excl. options
18.4M
Shares change
+3.2M
Total reported value, excl. options
$37.5M
Value change
+$6.56M
Number of buys
23
Number of sells
-12
Price
$2.04

Significant Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q4 2023

49 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18.4M shares of 87.4M outstanding shares and own 21.01% of the company stock.
Largest 10 shareholders include FMR LLC (4.75M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.36M shares), JOSH ARNOLD INVESTMENT CONSULTANT, LLC (1.86M shares), VANGUARD GROUP INC (1.78M shares), BALYASNY ASSET MANAGEMENT L.P. (1.25M shares), Kent Lake Capital LLC (1.09M shares), Triatomic Management LP (885K shares), CINCINNATI INSURANCE CO (700K shares), TIFF ADVISORY SERVICES, LLC (423K shares), and ELEMENT POINTE ADVISORS, LLC (398K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.